Clinical Trial 41066


Woodstock, GA 30189

Study Summary:

The purpose of this study is to determine if treatment with dempedoic acid (ETC-1002) versus placebo decreases the risk of cardiovascular events in patients who are statin intolerant

Qualified Participants Must:

• Age between 18 and 85 years
• History of, or at high risk for, cardiovascular disease (CVD) including coronary artery disease, symptomatic peripheral arterial disease, cerebrovascular atherosclerotic disease, or at high risk for a cardiovascular event
•Patient reported history of statin intolerance
• Men and nonpregnant, nolactating women
• Fasting blood LDL-cholesterol greater than 100 at screening

Qualified Participants May Receive:

Compensation for time and travel

Study is Available At:

North Georgia Clinical Research
1192 Buckhead Crossing, Suite A
, GA 30189
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 25 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.